AGP Picks
View all

AGP Executive Report

Last update: 10 hours ago

Work and Sleep: A Finnish cohort study found evening types had nearly 1.7 times the risk of disability pension as morning types over 12 years. The link weakened after researchers accounted for health and work schedules, and the study cannot show cause and effect. Flu Vaccination: Delayed vaccine deliveries have pushed some influenza vaccinations at Helsinki maternity and child health clinics to 16 November; vaccination weeks now run 16–27 November. Care Delays: Finnish patients have described waits of up to six hours at night in emergency departments, while a separate report says cancer treatment delays in Finland are linked to poorer outcomes than elsewhere in the Nordics. Family Support: A study across 299 Finnish municipalities found higher fertility rates where people reported stronger social support and more contact beyond their households. It shows an association, not that social ties cause people to have children.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Aug. 28, 2026

NOA Villas says sleep is becoming a luxury draw in Finnish Lapland

AGP

fallback image
Jul. 30, 2026

SGS Finland gains EU Battery Regulation Notified Body status

AGP

fallback image
Jul. 20, 2026

AMT Medical’s sutureless bypass system posts 1-year safety data

AGP

fallback image
Jul. 16, 2026

RAPIDÈ opens Singapore's first clinician-led recovery atelier

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Stakeholder Perspectives on Incorporating Patient Preference Information into Drug and Medical Device Regulatory Decision-Making in Korea

Stakeholder Perspectives on Incorporating Patient Preference Information into Drug and Medical Device Regulatory Decision-Making in Korea

Disseminated Mycobacterium colombiense Disease in a Person Living with HIV: Diagnostic and Therapeutic Considerations

Disseminated Mycobacterium colombiense Disease in a Person Living with HIV: Diagnostic and Therapeutic Considerations

Vitamin D Deficiency Among Hospitalized Children with Community-Acquired Pneumonia: Prevalence and Association with Disease Severity

Vitamin D Deficiency Among Hospitalized Children with Community-Acquired Pneumonia: Prevalence and Association with Disease Severity

COVID-19 Curriculum Disruptions and Future Preparedness in Iranian Medical Education: A National Mixed-Methods Study

COVID-19 Curriculum Disruptions and Future Preparedness in Iranian Medical Education: A National Mixed-Methods Study

Psychosocial Resources, Daily Tai Chi Practice, and Mental Health Among Chinese Undergraduates: A Mixed-Methods Study

Psychosocial Resources, Daily Tai Chi Practice, and Mental Health Among Chinese Undergraduates: A Mixed-Methods Study

A Preliminary Nomogram for Sarcopenia Screening in Cardiology Outpatients Incorporating Cardiac Structure, Function, and Clinical Variables

A Preliminary Nomogram for Sarcopenia Screening in Cardiology Outpatients Incorporating Cardiac Structure, Function, and Clinical Variables


fallback image
Oct. 15, 2026

EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe

GlobeNewswire, Inc.

fallback image
Oct. 7, 2026

Nouryon cleared by regulators to supply a plant-based, water-soluble pharmaceutical ingredient in China's expanding drug manufacturing market

GlobeNewswire, Inc.

fallback image
Oct. 5, 2026

Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing

GlobeNewswire, Inc.

fallback image
Oct. 16, 2026

Optivian expands into UK and Ireland with sales team in London and Dublin

EIN Presswire

fallback image
Sep. 24, 2026

AMSA and ŌURA Collaborate to Make Innovation Fest 2026 the Best Student-Led Health Tech Event Yet

EIN Presswire

fallback image
Sep. 24, 2026

Kasvu Therapeutics Raises €30 Million Series A Financing Round led by Hadean Ventures to Advance its Novel TrkB Potentiator into Clinical Development Targeting Neuropsychiatric Disorders

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Can the EU Step up Where the US is Stepping Back?
Play
Can the EU Step up Where the US is Stepping Back?
YouTube video thumbnail: How Finland Defeated Fascism
Play
How Finland Defeated Fascism
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Finland: Inside the Most Prepared Country on Earth
Play
Finland: Inside the Most Prepared Country on Earth
YouTube video thumbnail: The Baltic Sea Explained
Play
The Baltic Sea Explained

Video Title

Sign up for:

Health Daily Finland

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Daily Finland

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.